China SXT Pharmaceuticals, Inc. Gains 42.67%
Fri, Jan 10, 2020 at 05:30 PM
China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ) rocketted at $1.07, representing a gain of 42.7%. On Thu 09 Jan 20, SXTC:NASDAQ touched a New 2-Week Low of $0.75. From Wed 18 Dec 19, the stock recorded 35.71% Up Days and 26.67% Green Days
The share price of the company has been moving sideways in recent weeks.
About China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ)
China SXT Pharmaceuticals Inc is engaged in the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces(TCMP). The company sells Advanced TCMP, Fine TCMP, and Regular TCMP. Generating a majority of its revenue from the Advanced TCMP. Geographically, the firm generates a majority of its revenue from the People's Republic of China.
Top 10 Gainers:
- CounterPath Corporation (CPAH:NASDAQ), 304.12%
- Origin Agritech Limited (SEED:NASDAQ), 46.92%
- China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 42.67%
- Sorrento Therapeutics, Inc. (SRNE:NASDAQ), 39.59%
- Proteon Therapeutics, Inc. (PRTO:NASDAQ), 30.5%
- Lianluo Smart Limited (LLIT:NASDAQ), 28.57%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 28.54%
- Akari Therapeutics, Plc (AKTX:NASDAQ), 25.43%
- Aileron Therapeutics, Inc. (ALRN:NASDAQ), 24.97%
- Nektar Therapeutics (NKTR:NASDAQ), 24.69%